Company News

ANNOUNCEMENT

Dr. Red Thaddeus Miguel: Recipient of the Coveted Forty Under 40 Award

May 28, 2024

We are thrilled to announce that Dr. Red Thaddeus D. Miguel, our Vice-President and Chief Technology Officer, has been honored as one of this year's recipients of the prestigious Forty Under 40 award from the Ottawa Business Journal and the Ottawa Board of Trade.


The Forty Under 40 award has earned its reputation as the region's most coveted accolade for business leaders under the age of 40. This year, an impressive 163 nominations were submitted, 88 finalists were chosen, and Dr. Miguel was selected as one of the top 40, recognized for his outstanding business achievements, professional expertise, and impactful community involvement.


At Thera-Business, Dr. Miguel provides leadership and develops the strategic roadmap for health research projects and data analyses. His commitment to creating customized solutions ensures that we meet the diverse needs of our clients with precision and innovation. As a specialist in evidence-based practices and health research methodologies, he directs and oversees our health research initiatives, ensuring that each project is grounded in rigorous, data-driven approaches.


This award not only highlights Dr. Miguel's individual accomplishments but also reflects the collective dedication and excellence of the Thera-Business team. It validates the hard work, talent, and innovative spirit that define our company. At Thera-Business, we are driven by a commitment to serve our clients with the highest level of expertise and care, and this recognition underscores our unwavering dedication to excellence in every endeavor.


We extend our heartfelt congratulations to Dr. Miguel and all of this year's recipients. We are immensely proud of Dr. Miguel's achievements and the positive impact he continues to make in the field of health research.


Learn more about the award and see the full list of recipients here.

Return to News
We've completed 500+ projects for leading medical device and pharmaceutical companies, as well as government health agencies.